Steek is an AI-powered competitive intelligence platform that lets you research any market, competitor, or trend in 30 seconds. It monitors 40+ premium sources and generates deep analysis with competitive landscapes, key findings, action items, and foresight reports — all with citations.

Pick any market signal, trend, or topic. Steek instantly generates a deep competitive research report including executive summary, key findings, competitive landscape analysis, action items, and risk assessment — drawing from 40+ premium sources with full citations.

Steek is built for product managers, strategists, researchers, and decision-makers who need fast, reliable competitive intelligence. If you spend hours researching markets, competitors, or trends — Steek does it in 30 seconds.

What types of research can Steek generate?

Steek generates five types of intelligence: Quick Insights (instant signal analysis), Deep Research (comprehensive reports with competitive landscape), Foresight Reports (trend predictions and strategic forecasting), Visual Maps (interactive concept diagrams), and Video Intelligence (key takeaways from video content).

Is Steek free to use?

Yes, Steek offers a free tier with generous quotas for all features including competitive research, quick insights, foresight analysis, visual maps, and shareable report links. Premium plans unlock higher quotas and advanced features.

How fast is Steek compared to manual research?

Steek generates a full competitive research report — with executive summary, key findings, competitive landscape, action items, and citations — in about 30 seconds. The same analysis would typically take a human analyst 3-5 hours.

Steek

Smart Intelligence Tracking

Dashboard

Signal #128720NEUTRAL

AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5 billion - Fortune

100

AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5 billion Fortune

Google AI Healthcareabout 20 hours ago

Read Full Article

Explore with AI-Powered Tools

View All Signals

Explore more AI intelligence

Want to discover more AI signals like this?

Explore Steek

AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5 billion - Fortune | Steek AI Signal | Steek

AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5 billion - Fortune

Explore with AI-Powered Tools

Quick Insights

Deep Research

Visual Map

Foresight

Learn

View All Signals